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The impact of early life events is increasingly becoming apparent, as studies investigate how early childhood can shape long-term
physiology and behaviour. Fibromyalgia (FM), which is characterised by increased pain sensitivity and a number of aﬀective
co-morbidities, has an unclear etiology. This paper discusses risk factors from early life that may increase the occurrence or
severity of FM in later life: pain experience during neonatal life causes long-lasting changes in nociceptive circuitry and increases
pain sensitivity in the older organism; premature birth and related stressor exposure cause lasting changes in stress responsivity;
maternal deprivation aﬀects anxiety-like behaviours that may be partially mediated by epigenetic modulation of the genome—all
these adult phenotypes are strikingly similar to symptoms displayed by FM suﬀerers. In addition, childhood trauma and exposure
to substances of abuse may cause lasting changes in developing neurotransmitter and endocrine circuits that are linked to anxiety
and stress responses.
1.Introduction
The causes and underlying pathologies dictating and aﬀect-
ing the development of ﬁbromyalgia (FM) are not yet clear,
but as a syndrome aﬀecting between 2 and 4% of the
population, with a higher incidence in women [1, 2], it
is a hot topic in pain research at this time. As discussed
in detail elsewhere in this paper, FM constitutes a chronic
pain syndrome, concomitant with a myriad of symptoms,
including muscular stiﬀness and tenderness at speciﬁc
locations, chronic fatigue, cognitive and mood disturbances,
and insomnia. Documented pathophysiologies related to FM
include aberrations in neuroendocrine systems, dysfunction
in stress regulation and neurotransmitter function, and
alterations in brain structure and connectivity. In addition,
FM is linked to psychosocial and environmental triggering
factors. This paper will explain and discuss some of the
potential risk factors of early life adversity (ELA) that display
markedly similar outcomes that constitute some of the
later symptoms of FM. Pain researchers have clearly shown
that noxious events during early life can cause a number
of long-lasting changes in pain processing systems in the
older organism, which could contribute to the increased
pain sensitivity noted in FM patients. In addition, factors
such as premature birth and related exposure to stressors,
maternal deprivation, and physical or substance abuse in the
perinatal period can inﬂuence developing neurobiological
and psychological states in a number of ways, often causing
changes in adulthood similar to the disturbances seen in FM
suﬀerers. Early life pain, hospitalisation, deprivation, emo-
tional trauma, and abuse are discussed in this paper, with
speculation about their potential impact upon ﬁbromyalgia.
2. Risk Factor:PainfulExperiencesduring
InfantDevelopment
It is well established that the experience of pain during
infancy causes long-lasting alterations in pain processing
that extend well into childhood and adulthood [3–5]. This
adds weight to the need for eﬀective understanding and
management of pain in neonates, in order to minimise
later consequences of early pain experience (see [6, 7]).
Infants born with preexisting illnesses or under diﬃcult
circumstances, born preterm or needing early surgery, may
all need hospitalisation for treatment. In addition, the
incidence of premature birth and the necessary associated
critical care has increased over the last 20 years [8], and the2 Pain Research and Treatment
technology to aid survival has meant that infants as young
as 24 weeks postmenstrual age (PMA) can survive and
develop on the neonatal intensive care unit (NICU). In
these clinical settings, multiple painful procedures may be
performed daily for routine monitoring, in addition to any
necessary surgeries infants require—for example, Simons et
al. [9] found that during the ﬁrst 14 days of hospitalisation,
neonates were subject to an average of 14 painful procedures
per day. A more recent study [10] conﬁrmed these ﬁndings,
showing that neonates were exposed to a daily average
of 16 painful and/or stressful procedures and that up
to 80% of children were not given speciﬁc analgesia for
these procedures. This high number of procedures, perhaps
repeated over a number of weeks or months, aﬀects the
developing nociceptive circuitry of the infant in ways that
cause long-lasting changes in pain processing (see [3]) and
could explain some of the abnormalities in pain processing
displayed by FM patients.
2.1. The Eﬀect of Painful Stimulation on the Human Neonate.
Studies of ex-premature children provide compelling evi-
dence for the long-term eﬀects of human early pain
experiences. Walker et al. [11] recently presented data on
sensory sensitivity in a cohort of 307 extremely preterm
infants born at less than 26 weeks postmenstrual age (PMA)
in 1995 and followed throughout their lives so far (the
UK EPICure cohort). Quantitative sensory testing (QST)
established sensory thresholds in these children at age 11
and showed that these extremely preterm children had
signiﬁcantly decreased sensitivity to non-noxious mechanical
and thermal stimuli compared to age- and sex-matched
term born controls. A similar result has been seen in 9–12-
year-old children who had previously experienced neonatal
cardiac surgery—subjects were signiﬁcantly less sensitive to
nonnoxious mechanical and thermal stimuli at both the
previously operated site and noninjured areas [12]. The
foundations for this baseline hyposensitivity may be laid
whilst children are being cared for on the NICU—following
children with NICU experience at 4, 8, and 18 months of
(corrected) age, dampened pain responses to immunisation
and blunted nociceptive sensitivity to everyday bumps
are seen, compared to full-term controls with no NICU
experience [13, 14]. Hermann et al. [15] also found elevated
heat pain thresholds (i.e., decreased sensitivity) in children
who had been hospitalised for a prolonged period as infants
and had undergone repeated painful procedures as part of
their treatment.
Importantly and more relevant to FM, when pain-
exposed neonates are reexposed to noxious stimuli in later
life,hypersensitivitytothestimulusisobserved.Forexample,
when ex-NICU infants were tested on their perceptual
sensitisation to heat pain, where a constant temperature is
given for 30 seconds and the change in perception gauged at
the end, neonatally hospitalised children showed increased
sensitisation compared to nonhospitalised controls, who
habituated to the thermal stimulus [15]. Interestingly, heat
pain thresholds of all groups of children were increased in
the presence of the children’s mothers [16], highlighting the
importance of social support on the pain experience (which
has also been shown to be eﬀective in alleviating the impact
of FM [17]). More studies conﬁrm the hypersensitivity seen
in ex-premature infants after noxious stimulation in the
older child. For example, behavioural sensitivity to noxious
mechanicalstimuliattheheelpersistsforatleasttheﬁrstyear
of life after repeated NICU heel lance experience [18]. Deep
somaticandvisceralnoxiousstimulationresultingfromearly
invasive surgery leads to sensitisation of pain responses to
later surgery, particularly in regions of the body served by
the same spinal nerves as those aﬀected by the initial surgery
[19]. These eﬀects are not limited to surgical pain. Children
who suﬀered from burn injuries in infancy (6–18 months of
age) showed lower mechanical pain thresholds and greater
perceptual sensitisation to both heat and mechanical pain
stimuli at sites not originally aﬀected by the burn at ages 9–
16 [20]. An interesting study by Buskila and colleagues [21]
may be particularly relevant to adult ﬁbromyalgia patients:
this study showed that ex-NICU neonates had, as 12–18 year
olds,signiﬁcantlymore“tenderpoints”andlowertenderness
thresholds than matched full-term children. Seeing as FM
diagnosis has been partly based on soreness at a certain
number of “tender points”, it could be informative to follow
these adolescents over time and assess later FM prevalence.
Summarizing the above, hypo- as well as hypersensitivity
has been observed as a consequence of early life pain. The
way in which sensory processing is altered by early life
pain may be dependent on several factors. For example, the
developmental time point at which injury is experienced can
dictate the lasting eﬀects of these injuries (see discussion of
the “critical period” in the section “Early Life Exposure to
Pain May Inﬂuence Fibromyalgia”). In addition, the type
of noxious insult (surgical, burn, etc.) and therefore the
relative proportion of nociceptors that are activated (i.e.,
C ﬁbre or A delta nociceptors) may inﬂuence the exact
nature of altered sensory processing. Finally, as detailed in
thefollowing section, it may bethatdiscrete CNS systemsare
responsible for decreases in tactile and thermal sensitivities
and the hyperalgesia seen in neonatally injured humans.
Animal models of neonatal pain show markedly similar
eﬀects as those seen in humans and are crucial to identify
and understand cellular mechanisms that are impossible to
study in humans. The development of nociceptive circuitry
has been studied in-depth, and the neurobiology underlying
long-lasting changes is becoming increasingly clear (see [3]).
2.2. The Neurobiology Underlying Long-Term Eﬀects Can Be
Studied in Animal Models. The utility of animal models
is illustrated by evidence showing that the generalised
hyposensitivity to mechanical and thermal stimuli shown in
humans with early life pain experience (e.g., [14]) is likely
mediated by changes in the brainstem regions that modulate
ascending aﬀerent input, in particular the periaqueductal
grey (PAG) and rostroventral medulla (RVM), which can
either enhance or suppress nociceptive input from the spinal
cord [22–25]. In the rat, these areas (PAG and RVM)
mature over the ﬁrst three weeks of age [26–28], which
corresponds approximately to the time span from the thirdPain Research and Treatment 3
trimester of gestation to adolescence in human [29, 30].
La Prairie and Murphy [31] injected carrageenan (which
causes short-term inﬂammation lasting around 24 hours)
into the hindpaw of male and female rats on the day of birth
and saw that, in adulthood, the animals showed decreased
sensitivity to thermal stimulation in both the previously
injured and uninjured paws. In addition, increased levels
of endogenous opioid mRNA were seen in the PAG of the
adult animal, and blockade of brain opioid receptors with
naloxone abolished this decreased pain sensitivity, leading
the authors to speculate that neonatal inﬂammation induces
an upregulation in endogenous opioidergic tone that is
maintained into adulthood, so that the adult displays a
systemthatisconstitutively“dampening”aﬀerentspinalcord
input, leading to decreased pain responses [32].
This suggests that early pain can alter endogenous pain
inhibitorycircuitry.However,FMpatientsshowhyperalgesia
rather than hyposensitivity [33–36]. Enhanced nociceptive
responsiveness is consistently observed in neonatally injured
animalsuponadultreinjuryandlikelyresultsfromanumber
of changes in nociceptive circuitry induced by early pain
exposure, all of which result in a nervous system “primed”
to respond in an enhanced manner to a new insult. For
example,neonatalinﬂammationcausesthermalhyperalgesia
in rat pups that lasts from several weeks up to adulthood
[37–39]. This inﬂammation and concomitant release of
inﬂammatory and trophic molecules results in enhanced
spinal neuronal responses to paw pinch in the adult, as
well as increased primary aﬀerent nerve ﬁbre innervation
of the dorsal horn of the spinal cord [40]. Inﬂammation-
induced alterations in the developmental connectivity of the
spinal cord [41] and/or sprouting of nerve ﬁbres at the
skin also result in an increased nociceptive response [42].
Neonatal skin wounds, like inﬂammation, cause drops in
mechanical withdrawal thresholds at the site of injury and
increase in dorsal horn receptive ﬁeld size weeks after the
wound had healed [43, 44], as well as causing release of
nerve growth factors leading to hyperinnervation of the
skin, and increased sensitivity to noxious stimuli in later
life [45]. This is consistent with human studies showing
hypersensitivity after injury in children, especially those with
previoussurgicalhistory[19,46,47].Therefore,theapparent
contradictionbetweengeneraliseddecreasedsensitivitiesand
hyperalgesic responses to new noxious stimulation may in
part be due to discrete CNS processing systems dictating
behavioural responses, for example, enhanced endogenous
pain inhibition at a brainstem level, but increased hypersen-
sitivity/hyperinnervation at a spinal level.
2.3. Early Life Exposure to Pain May Inﬂuence Fibromyalgia.
As explained above, whilst La Prairie and Murphy [31]
showed that animals subject to neonatal inﬂammation
showedgeneralisedhypoalgesiatothermalstimuliatbaseline
in adulthood, when animals were reinjured as adults,
animals were more sensitive to noxious thermal stimulation.
Importantly, all of these eﬀects were greatest in female
animals. This ﬁnding might be relevant to ﬁbromyalgia
syndrome, as the incidence of FM is greater in women [48].
Furthermore, disturbances in descending pain modulation
havebeenreportedinFMpatients[49,50]andpatientsshow
decreased blood serum levels of serotonin and lower CSF
levels of serotonin and noradrenaline metabolites [51–54].
This may be relevant to FM, as there is a discrete descending
serotonergicsystemprojectingfromtheRVMthatmodulates
spinal cord excitability [55–59]. Furthermore, noradrenergic
signalling, originating from the locus coeruleus, has a role
centrally in feedback inhibition of pain (see [60]).
The developmental timing of any injury determines
potential long-term eﬀects, leading to the concept of a
“critical period” of nociceptive development, within which
pain experience permanently alters pain processing (see [5,
61]). To illustrate, giving a skin incision to the hindpaw
of a neonatal rat at postnatal days (P) 3 or 6 produces
an increased pain response to a repeat incision 2 weeks
later. If, however, the initial incision is performed after
the critical period (at P10, 21, or 40 followed by repeat
incisions 2 weeks later), the enhanced hypersensitivity to
the later incision is not seen [61]. Understanding the
concept of a “critical period” of nociceptive development
may be useful for determining some of the root causes of
ﬁbromyalgia—as human infants born prematurely display
long-term alterations in pain processing, it is possible that
early pain experience within this time window contributes
to some of the adult pain in FM. At this time, there is very
little literature that attempts to delve into the neonatal and
childhood life of current FM patients.
2.4. Adequate Pain Management of Neonates May Decrease
FM Prevalence in Adults. In order to prevent these physio-
logical disturbances, adequate pain management for human
neonates is an important clinical issue. Pain management
of neonates is a diﬃcult area, as neonates cannot give
verbal feedback on their pain experience, and are physiolog-
ically very diﬀerent to the adult state that dictates dosage,
metabolism and eﬃcacy (i.e., [7]). Current treatments
include morphine and benzodiazepines both for postsurgical
pain and general sedation on the NICU [62], as well as non-
pharmacological interventions such as the administration
of sucrose for acute procedures including heel lance [63]
(although the eﬀectiveness of these interventions and the
long-term eﬀects of chronic exposure to sucrose and drugs
such as morphine are not yet clear [64, 65]). The eﬀects of
these continue to be studied, and given the long-term eﬀects
of early pain as discussed above, adequate pain management
for neonates might reduce various pain syndromes in later
life, including ﬁbromyalgia. The importance of adequate
analgesia for neonatal procedures is illustrated in a seminal
paper by Taddio et al. [46]. They performed a double-
blind, randomized, controlled trial (RCT) on the eﬀects
of a topical anaesthetic (EMLA cream) used during male
neonatal circumcision, which has traditionally been done
without anaesthesia or analgesia. Looking at pain responses
in the infants when they were later vaccinated at 4–6 months,
boys who had been treated with the EMLA cream when
circumcised showed lower pain responses than those who
received no anaesthesia, and the circumcised groups both
showed higher pain scores than uncircumcised controls.4 Pain Research and Treatment
3. Risk Factor:PrematureBirth and
RelatedStressors
Asdiscussedabove,painduringtheneonatalperiodcanalter
the nociceptive processing pathways of an organism for life,
potentially impacting upon the development of ﬁbromyalgia
in later life. Many of the human studies mentioned in the
previous section recruited infants born prematurely, needing
the intensive care unit for survival. The NICU is a strange
and abnormal environment in comparison to the womb, and
premature infants are exposed to many stressful stimuli in
addition to repeated nociceptive procedures, such as light,
noise, tactile stimulation, surgery, medication, and maternal
separation, all of which could feasibly aﬀect development
[66]. Indeed, even the act of nursing very premature infants
(changing diapers etc.) causes increases in stress hormones
[67]. In addition to the long-term eﬀects of increased pain
sensitivity in these children are eﬀects upon stress regulatory
systems, where a large body of evidence suggests that
prematurity and the resulting experiences on the NICU can
permanently alter in particular the hypothalamic-pituitary-
adrenal (HPA) axis. As this is shown to be disturbed in FM
patients [68–71], it is possible to speculate that premature
birth in itself may inﬂuence the occurrence of FM in adults.
3.1. Premature Birth Impacts upon the Body’s Response to
Stressors. The HPA axis is the body’s stress-response system.
Cells of the hypothalamus produce corticotropin-releasing
factor (CRF) in response to an environmental stressor, and
a cascade of events ultimately causes adrenaline release and
the production of the “stress hormone” cortisol. Under
normal circumstances, adrenaline and cortisol release is
terminated via a negative feedback circuit. In FM, however,
HPA axis regulation appears to be abnormal. Whilst the
precise dysfunctions in stress regulation via the HPA axis
are not clear at this point (some studies ﬁnd FM patients
show hypocortisolism (see [72]), whilst others describe
hypercortisolism and HPA hyperactivity [68, 69, 73]), what
is clear is that HPA axis function is not normal in many
patients. The discrepancy between ﬁndings of hyper- and
hypocortisolism may be due to a number of factors. For
example, disease-speciﬁc patient characteristics, such as
symptom proﬁles and comorbidities, as well as disease-
nonspeciﬁc characteristics, such as age, gender, personality
traits, and socioeconomic background, can aﬀect results.
In addition, markers of HPA axis function diﬀer between
studies (e.g., basal levels or evoked cortisol responses) as
do the time points of measurement (e.g., upon waking or
followingdiurnalﬂuctuations),inadditiontoothertechnical
details. In instances where the literature does not permit any
conclusions on the direction, we refer to alterations in HPA
axis function, rather than increases or decreases.
Nevertheless, the way in which premature birth alters
cortisol levels and cortisol responses compared to term-
born controls is relatively unambiguous. Grunau et al.
[66] propose that early stressors such as those routinely
experienced in the NICU can impact upon development of
the HPA axis by causing consistent release of adrenaline and
cortisol and increase the “allostatic load” of the neonate—
the concept of “allostasis” explaining how an organism’s
physiological systems ﬂuctuate over time in order to meet
the demands of external stressors, in an attempt to regain
homeostasis (bodily equilibrium). The impact of chronic
stress and the accompanying neuroendocrine responses may
also ultimately cause long-lasting damage to bodily organs
and contribute to chronic disease development [74]. In
preterm neonates, this may manifest as a life-long shift in
HPA axis balance.
Basal cortisol levels are often low in neonates on the
NICU in comparison to term infants, which is unexpected
considering the length of time that infants spend there
and the stressful procedures the still-developing neonate is
subject to [75, 76]. Grunau and colleagues have published
a series of studies giving convincing evidence that NICU
experience causes “resetting” of the endocrine stress systems,
by measuring cortisol levels after noxious experiences in
ex-preterm infants, either whilst still on the NICU (short-
term eﬀects), or in the months to years following. When a
clinically required heel lance was done whilst infants were
still on the NICU, the earliest premature infants born at
less than 28 weeks gestational age (i.e., approximately 3
months premature) showed a dampened cortisol response
to heel lance. In addition, higher cumulative exposure to
neonatal procedural pain over the length of stay in the
NICU was related to lower cortisol release to standard
nursing procedures [77]. When immunised at 2–4 months
(corrected) age, low gestation age (LGA) boys (<32 weeks),
but not girls, showed lower cortisol concentrations than full-
term infants after injections, although facial and heart rate
responses did not diﬀer between groups [78].
When studied over a longer period of time, we see
that this early dampened cortisol response in premature
infants changes to elevations in cortisol levels and responses
when the children are older. At 8 months old, infants
born at extremely low gestational age (≤28 weeks) with
previously low basal cortisol levels, showed elevated basal
levels as well as greater increases in cortisol response to
stressors,comparedtoterminfants.Inthesechildren,greater
increases in cortisol were associated with higher numbers
of skin-breaking procedures experienced in the past on the
NICU [79]. Grunau et al. [80] followed the time course of
this “switch” from low to high stress hormone levels and
found that at 3 months corrected age, basal cortisol levels
were lower than term controls, but, at 8 and 18 months,
the youngest ex-premature infants had signiﬁcantly higher
cortisol levels than term controls. The authors speculate
that the HPA axis has been “reprogrammed” by NICU
experience. Recent work has replicated the ﬁnding that
premature children born onto the NICU later have higher
basal cortisol levels compared to term-born controls at both
18 months [81] and upon waking in 8–14 year old ex-
premature infants [82].
Animal studies support the existence of a developmen-
tal shift from low to high cortisol levels after perinatal
corticosteroid exposure, and these higher levels of cortisol
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of corticotropin-releasing hormone (CRH) mRNA and
glucocorticoid (GC) receptors in the amygdala (e.g., [83,
84]). In humans, this shift from low to high levels over
development may be inﬂuenced by the fact that the mothers
at risk of giving birth prematurely are routinely given
corticosteroidstodelaybirthandenhanceinfantsurvivaland
lung function—an intervention which suppresses cortisol
secretionintheinfantwhenborn[85]yetcausesanincreased
cortisol response after heel lance at 24 hours after birth [86].
Further work is needed to address the impact of perinatal
glucocorticoid exposure on the stress response axis in later
life.
3.2. Prematurity May Contribute to Adult FM Symptoms via
theHPAAxis. Theaboveevidencehighlightshow premature
birth and the stressors associated with it can inﬂuence the
physiological response to stress and “reset” the balance of
the HPA axis response. Seeing as FM patients routinely
show imbalances in the stress response, it is reasonable
to hypothesise that premature birth may be a risk factor
for developing FM in later life. Indeed, Klingmann et al.
[87] show that of 93 female FM patients, 62% reported
a gestation length of <38 weeks, which was related to a
lower cortisol response upon waking when compared to
full-term FM patients. The authors speculate that enhanced
glucocorticoid levels in the mother during pregnancy or
in response to premature birth aﬀect the development of
the adrenal glands in the foetus/premature infant, rendering
the HPA axis less capable of dampening stress responses
to later stressors. This in turn may disinhibit responses to
physical or psychological stress and aﬀect brain function,
resultinginenhancedresponsestopainandincreasedfatigue
levels.Supportforthishypothesiscomesfromanimalstudies
of prenatal glucocorticoid exposure, where dam rats are
exposed to substances that increase HPA axis activity (such
as glucocorticoid receptor agonists), in the third trimester
of gestation. Results show that the adrenal glands and brain
weight of the adult oﬀspring are smaller, stress regulation is
compromised, and cognitive dysfunction is seen in tests of
memory as well as anxiety-like behaviour, with the eﬀects
exacerbated in female oﬀspring [88–93].
3 . 3 .C o g n i t i v eS y m p t o m so fF MM a yA r i s ef r o mD i ﬀerences
in Brain Development Caused by Premature Birth. One
symptom of FM, colloquially called “ﬁbro-fog” by suﬀerers,
constitutes cognitive deﬁcits, with patients complaining of
diﬃculties in memory and attention that mimic the eﬀects
of an extra 20 years of ageing (e.g., [94, 95]). Additional
evidence that prematurity may inﬂuence the development of
FM comes from studies showing that the risks of cognitive
and psychiatric impairment are much greater in ex-preterm
infants. The EPICure cohorts (born at ≤25 weeks gestation)
have recently had their cognitive abilities and psychiatric
proﬁles investigated at 11 years of age. Results showed
that the children born at the youngest preterm ages are
at higher risk of ADHD, autism spectrum, and emotional
disorders [96] and show increased incidences of learning
impairments and poor academic attainment [97]. Other
meta-analyses and epidemiological studies have conﬁrmed
the increased risk for psychiatric symptoms and poorer
academic performance in older childhood after premature
birth [98–100].
Brain imaging of ex-preterm infants compared to full-
term controls has shown underlying changes in brain
structure and function that may help explain some of these
deﬁcits. Cortical surface area is decreased at full-term in
extremely preterm infants [101], and the incidence of white
matter abnormalities persisting past 18 months (corrected)
age is increased [102]. Thalamic volume is also reduced
in preterm children at term-equivalent age [103]a n da t2
years of age, and connectivity between the thalamus and
cortexmaybedisruptedinex-pretermchildren[104].Seeing
as the premature brain is still developing at a rapid pace
and as myelination occurs during late preterm maturation
[105], it is likely that prematurity inﬂuences white matter
development, helping to explain why later cognitive deﬁcits
may arise. If premature birth becomes a proven risk factor
for ﬁbromyalgia, the neural bases of “ﬁbro-fog” may become
better understood in the adult.
4. Risk Factor: Maternal Deprivation
As discussed above, early pain experience and prematurity
may be risk factors for FM development in later life. Prema-
turity might be a risk factor in combination with the high
exposure to additional stressors, including maternal depri-
vation. Relatively detailed information is available on the
eﬀects of maternal deprivation on the developing organism,
and therefore maternal deprivation is discussed separately.
Animal models of deprivation have proven extremely useful
in illustrating the eﬀects of deprivation from the primary
caregiver (generally the mother) and the strong role for the
ﬂuidity of genetic expression during early life in the shaping
of the adult phenotype. The study of epigenetics, or how
the environment inﬂuences the activation and expression of
diﬀerent genes, has provided fascinating insights into this
ﬂuidity.
4.1. Maternal Deprivation in Animal Models Inﬂuences Later
Stress Responses. Animal models of maternal deprivation
often use rats and generally employ a paradigm whereby
pups are separated from the mother for at least an hour
per day, much longer than the 20–25 minutes of absence
that dam (mother) rats are routinely away from the nest
[106]. When neonatal rats are exposed to these prolonged
periods of deprivation during the ﬁrst weeks of life, a
number of physiological and behavioural changes occur
in the adult animal. For example, rats separated from the
dam for 180 minutes per day from postnatal day (P) 2–
14 show elevated levels of CRF mRNA as adults, which
causes adrenaline and cortisol release via activation of the
HPA axis [107, 108]. They also show more anxiety-like
behavioursasadultsandanincreasedpropensitytoconsume
alcohol [109, 110]. Accordingly, maternal deprivation has
now been used to model various psychiatric states such as
anxiety [111], addictive disorders [112], and schizophrenia
[113], and a recent study by Uhelski and Fuchs [114]6 Pain Research and Treatment
showed that maternally deprived animals showed increased
active avoidance of environments in which pain had been
experienced, suggesting enhanced supraspinally mediated
responses to pain. The importance of maternal presence is
further illustrated by work with monkeys: infants reared
in the absence of an adult caregiver but together with
age-matched peers develop chronic anxiety-like behaviours
and disordered cortisol levels to stressors (suggesting HPA
axis imbalance), similar to FM symptoms [115]. Taken
together, these data show that maternal deprivation has been
associated with three important disturbances found among
FM patients, namely, alterations in the HPA axis, increased
anxiety, and increased pain responses [116].
Short-termseparationofpupsconverselycausesopposite
eﬀects to longer maternal deprivation. If pups are subject
to only 15 minutes of deprivation, the adult animals
display more social contact and better stress-coping abilities
compared to animals deprived for longer periods [117–121].
These eﬀects seem to be mediated by the maternal style of
the dam upon reunion with the pups—mothers of pups
separated for short periods engage in more licking/grooming
and arched-back nursing (LG-ABN) when reunited com-
paredtodamsofpupsseparatedformoreprolongedperiods.
Dams that engage in high levels of this nursing style produce
oﬀspring that show more eﬃcient stress regulation, as
measured by corticosterone (the animal equivalent of CRH)
responses to stress and feedback sensitivity of the HPA axis
[122, 123]. In fact, the maternal LG-ABN style (either high
or low) causes individual diﬀerences in stress responsiveness
and emotionality that remain stable in the adult oﬀspring
[124] and is in itself a trait that is passed on to female
oﬀspring. Cross-fostering studies, where pups from low or
highLG-ABNdamsarerearedbydamsshowingtheopposite
LG-ABN behaviour illustrate that female oﬀspring will show
nursing styles akin to their “foster” dam rather than their
biological dam [125]. Further evidence for the ﬂuidity of
these behavioural phenotypes comes from evidence that low
LG-ABM dams rearing litters in a socially-enriched environ-
ment produce oﬀspring showing enhanced exploration and
licking/grooming behaviour of their own oﬀspring [126].
The eﬀects upon adult phenotype that depend on
maternal style are regulated by changes in DNA methylation
of the infant genome, leading to activation or silencing
of certain genes, and alterations in levels of, for example,
glucocorticoid receptors [122], neurotrophic factors and
speciﬁc neurotransmitter receptors in the hippocampus
[127]. Serotonin (5-HT) turnover (as seen by measures of
5-HT levels compared to levels of 5-HT metabolites) is
also increased in maternally deprived animals [128], and
expression and levels of serotonin receptors and transporter
proteins altered [129, 130]. This is particularly relevant
to FM, as the serotonergic system has been implicated in
theaﬀectivecomponentsassociated withFM—cerebrospinal
ﬂuid levels of 5-HT metabolites are decreased in patients
[53], serotonin antagonists are eﬀective drugs for some FM
patients with no associated depressive comorbidities [131],
and increased incidence of a speciﬁc genetic polymorphism
in the 5-HT transporter gene has been identiﬁed in FM
patients [132], although the exact disorders in serotonergic
signalling are not yet clear [133]. However, some of the
heterogeneity in FM patients may arise due to epigenetic
alterations that occurred during early infancy. To date, no
research has been conducted on this speciﬁc question.
4.2. Quality of Maternal Attachment Aﬀects Pain Processing.
The quality of the relationship between child and primary
caregiver (generally the mother) can also dictate emotional
reactivity throughout life and the type of attachment style
that an individual will form with others throughout their
life. Bowlby ﬁrst developed the idea of “attachment theory”,
studying the bond between child and mother and suggested
thatasecureattachmentstyleisthemostbeneﬁcialforinfant
development [134, 135]. Since then, studies have shown
that disordered attachment styles are linked to chronic pain
and problems coping with pain (see [136]). For example,
chronicpainpatientswithhighlevelsofavoidantattachment
self-scored pain intensity more highly, and patients with
fearful attachment styles display increased levels of pain
catastrophising, linked to anxiety levels [137, 138]. In acute
paintests,adultsshowingsecureattachmentstylesratedpain
as less intense and anxiogenic [139]. Importantly for FM,
secure attachment formation is linked to the dopamine and
opioidergic system in both animals and humans [140, 141],
suggesting that a secure early attachment between infant
and parent could be protective against developing FM in
later life. Hallberg and Carlsson [142] indeed mention the
overrepresentation of individuals with insecure attachment
styles in the chronic pain patient population.
5. Risk Factor:Childhood Physicaland
PsychologicalTrauma
Physical and sexual abuse during childhood are well-
documented risk factors in the development of ﬁbromyalgia
[143–146], and two recent meta-analyses link childhood
incidence of physical and sexual abuse with FM [147,
148]. Early life abuse carries with it the burden of a
number of other behavioural and pathological problems,
including increased incidence of depression, posttraumatic
stress disorder, alcoholism, substance abuse, obesity, ill
health, and suicide ([149; see 150]). A number of these are
also comorbidities in FM. It is possible that the impact of
early abuse and trauma contributes to FM via disruption
of neurotransmitter systems such as the serotonergic and
dopaminergic systems and impacts stress-management via
the HPA axis [151–155].
5.1. A High Incidence of Childhood Abuse Is Reported in FM
Patients. Self-report studies, where patients are questioned
on their childhood history, consistently show increased early
life adversity in FM patients. Goldberg et al. [156]f o u n d
that three diﬀerent groups of chronic pain patients (facial
pain, myofascial pain, and FM), all had a history of abuse
in nearly 50% of cases, rising to 65% in the ﬁbromyalgia
group. In particular, females with an alcoholic parent were
likelytobemembersoftheFMgroup.HallbergandCarlsson
[142] conducted in-depth interviews with 22 FM patientsPain Research and Treatment 7
and describe “abundant examples of early loss (and...) high
degree of responsibility early in life,” and Anderberg et
al. [157] found that, of 40 female FM patients, 51% had
experienced very negative childhood or adolescence life
events, compared to 28% in healthy age-matched women.
Nicolson et al. [158] found an association of self-reported
childhood abuse and neglect with FM patients’ daily cortisol
levels, ﬁnding the most disordered cortisol responses in the
patients reporting the highest levels of sexual and emotional
abuse. This suggests that early abuse further impacts upon
the HPA axis, which shows aberrant functionality in FM in
patients with no history of abuse [71]. Childhood rape has
also been strongly associated with a lifetime diagnosis of FM
[147].
The loss of a parent during early childhood is an
emotionally traumatic event and is associated with altered
daily cortisol levels in the adult, particularly in men [159,
160].Poorqualityfamilyrelationshipsduringchildhoodalso
cause changes in cortisol release in response to a stressful
event [161]. In addition, early-life stress and trauma has
been shown to be a signiﬁcant predictor of levels of CRF
in cerebrospinal ﬂuid (CSF) in non-FM subjects [162], and
Danese et al. [163] found an association between early-life
maltreatment and adult blood levels of C-reactive protein, a
marker of inﬂammation. Speciﬁc to ﬁbromyalgia, McLean et
al. [164] showed that women with FM who reported sexual
orphysicalabuseintheirpersonalhistorieshaddiﬀerencesin
CSF levels of CRF compared to nonabused FM women, and
Weissbecker and colleagues [165] found that a similar group
of FM women abused in childhood had disordered diurnal
cortisol levels.
However, studies based on the self-report of FM patients
can be diﬃcult to verify. Adult life experiences may bias
memories from early life, and it is possible that FM pa-
tients, due to their current pain and comorbid states, be-
come self-centred and preoccupied with the pain, and
potentially overemphasise traumatic memories [166, 167].
Longitudinal studies following children and young people
who have suﬀered from documented abuse, for example,
children in social care, would be useful in order to avoid this
confound. Epidemiological studies of socioeconomic posi-
tion (SEP) during childhood have shown that lower SEP
during childhood is a predictor of chronic widespread pain
in later life [168]. Whilst socioeconomic status incorpo-
rates a large number of factors, trauma-related hospital-
isations are more prevalent in children from lower soci-
oeconomic statuses who have less access to appropriate
healthcare [169–172].
6. Risk Factor:PerinatalExposure to
Substances of Abuse
Serotonin is not the only neurotransmitter system altered
in ﬁbromyalgia—dopamine and opioid neurotransmitter
disturbances are also reported that may, in part, result from
interference with these developing systems during pre- or
early postnatal life. Dopamine responses of FM patients to
painfulstimuliarelowerthanthoseofhealthysubjects[173],
and low CSF levels of dopamine (as well as serotonin and
norepinephrine) metabolites are seen in patients [52]. Fur-
thermore,theopioidsystemiscloselylinkedtodopaminergic
signalling, constitutes an important endogenous antinoci-
c e p t i v es y s t e m ,a n di sa l t e r e di nF M[ 174, 175]. Exposure
to a number of substances during early life will impact
upon the development of these neurotransmitter systems.
For example, exposure of the foetus to alcohol induces
dysfunction in dopaminergic and serotonergic systems and
willpersistentlyaﬀectthedevelopmentoftheHPAaxis[176–
178], all of which are, as mentioned, disturbed in FM.
6 . 1 .E a r l yO p i o i dE x p o s u r eC a u s e sL o n g - L a s t i n gC h a n g e s
in Nociceptive Systems. Early exposure to opioids, such as
exposure of the foetus to heroin or methadone during
pregnancy, or prolonged morphine administration after
birth, for example, on the NICU, causes lasting changes
in opioid signalling. If exposure occurs prenatally, it can
result in the newly born infant undergoing withdrawal
symptoms very soon after birth, the so-called neonatal
abstinence syndrome (NAS) [179]—an eﬀect mirrored in
animal models of early drug dependence [180]. Morphine
is used in the NICU to provide sedation in neonates
requiring mechanical ventilation and to improve tolerance
of ventilation and comfort of the infant. The lasting eﬀects
of this are not yet well-characterised [65, 181], although
it is known that chronic morphine administration causes
changes in mu-opioid receptor density and sensitivity that
desensitises older animals to opiate analgesia [182, 183].
As the opioidergic and dopaminergic systems are crucial
for endogenous modulation of pain, and this modulation
seems to be disordered in ﬁbromyalgia, longitudinal studies
of early life exposure to opioids may help explain some of
the disturbances in opioid function seen in FM. Positron
emission tomography (PET) studies would be useful to
investigate if the altered opioid receptor activity seen in FM
patients is related to early life opioid exposure. Harris and
colleagues [175, 184] have shown that FM patients show
alterations in mu-opioid receptor availability, but a history
of opioid use was one of the exclusion criterion for these
studies, meaning that the impact of early life exposure to
opioids is not yet known in terms of later FM prevalence.
6.2. Dopamine Overexposure during Early Life Aﬀects HPA
Axis Function, and May Be Mediated by Epigenetic Factors.
Dopaminergic drugs such as cocaine and amphetamine
increase anxiety-like behaviours in animal models of abuse
during pregnancy [185], and cocaine activates the HPA
axis by potentiating adrenocorticotropin hormone (ACTH)
release, which in turn stimulates the adrenal glands to
produce adrenaline and cortisol [186]. Increasing evidence
now suggests that prenatal exposure to drugs of abuse
(including alcohol, cocaine, and amphetamine) may be toxic
to developing dopamine-rich areas such as the basal ganglia
(see [187]). After birth, studies on the development of the
dopamine system suggest that functional connectivity in
the young animal, particularly to frontal cortical areas, is
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possible thatthebalancebetweentonic andphasic dopamine
release will also be aﬀected by exposure of the developing
system to excessive dopamine activation, impacting upon
later pain control mechanisms [190]. Therefore, early life
exposure to increased levels of dopamine could help explain
the aberrant dopaminergic functionality seen in FM patients
[173, 191]. Interestingly, genetic polymorphisms linked to
FM include the val158met polymorphism (in the gene coding
for catechol-o-methyltranferase, an enzyme that metabolises
dopamine) [192] and the dopamine D4 receptor [193]. Con-
sidering that epigenetic eﬀects impact upon stress regulation
in maternally deprived animals, it is possible to speculate
that early life events cause epigenetic changes, which may
interact with the above polymorphisms to produce an adult
phenotype at increased risk of developing FM. Indeed, self-
report studies of FM patients show higher levels of reported
parental drug and alcohol abuse in comparison to other
groups of other chronic pain patients [194, 195].
7. Conclusions
Fibromyalgia is classiﬁed as a disorder of pain processing and
stress regulation, often along with comorbidities of anxiety
and depression; the amount of evidence that links early life
adversity to pain, stress, and emotional problems in later
life strongly suggests that these adverse events and traumas
could increase the risk of developing FM in adulthood.
At this point, research has shown that FM patients self-
report high levels of early adversity and indicates that early
life circumstances aﬀecting later pain processing and stress
regulation may be more prevalent in FM. However, there is
little evidence to conclusively link the two, for example, by
proving that maternal deprivation or increased stress during
pregnancy increases the incidence of FM.
This paper has focused on the evidence showing that
painful procedures during early life cause long-lasting
changes in pain processing and suggests that high exposure
to painful experiences in early life may partially explain
the increased pain sensitivity shown by FM patients. In
addition, childhood adversities and maternal deprivation
are also discussed in terms of the eﬀects they have on
stress-regulatory systems in the older organism, so again
are potentially sources of the disorders in cortisol levels
and stress response seen in FM patients. As previously
mentioned, the precise dysfunctions in stress regulation via
theHPAaxisarenotyetclearinFMpatients,butwhatisclear
is that the body’s stress regulatory systems are compromised,
and it is possible that the precise nature and combination of
each individual’s childhood experience may be contributing
to the overall symptomatology of FM.
Exposure of the developing brain to perinatal stress and
glucocorticoids during critical periods of development may
aﬀect the long-term function of areas involved in stress
regulation such as the hippocampus and amygdala and help
explain the “ﬁbrofog” and anxiety disorders prevalent in FM.
Furthermore, impairments in stress regulation caused by
earlyexposuretostressorssuchasincreasedmaternalcortisol
levels, pain, or maternal deprivation may also partially
explain the increased pain sensitivities seen in FM patients.
Finally, as pain is itself a stressor, the pain experienced by
FM patients may be acting in a positive feedback manner
to further increase anxiety levels and impact upon stress
regulation. Whilst FM is unlikely to be due to a single
factor, it is possible that the factors outlined in this paper,
concomitant with a number of other factors such as a genetic
predisposition to enhanced pain sensitivity, stressful life
experiences in adult life, and the inﬂuence of sex hormones,
may combine or interact to create a phenotype at higher
risk of developing this form of chronic pain. Teasing apart
potential inﬂuences and their mechanisms may help treat
suﬀerers or, in fact, decrease the risk of future suﬀering.
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